23 Oct 2025 | 3 Mins Read
Cipla, Eli Lilly announce Yurpeak for Indian market
Flipitmoney
Cipla Ltd partnered with Lilly India to distribute and promote tirzepatide under the brand name Yurpeak, the second tirzepatide brand in India. Yurpeak will be available in six dose strengths through a multi-dose single-patient-use prefilled pen, enabling personalised treatment plans. Pricing for Yurpeak will remain the same as Lilly's Mounjaro.